Dr. Agarwal's Health Care Limited (NSE: AGARWALEYE) and PARK MEDI WORLD LIMITED (NSE: PARKHOSPS) are both listed in the Hospitals and Healthcare Centers industry. Dr. Agarwal's Health Care has a market capitalisation of ₹16,290 Cr and PARK MEDI WORLD ₹9,670 Cr, as of 9 Nov 2026. Their P/E ratios are 122.9 and 34.5 respectively. Return on equity is 8.31% for Dr. Agarwal's Health Care and 13.00% for PARK MEDI WORLD.
| Metric | Dr. Agarwal's Health Care | PARK MEDI WORLD |
|---|---|---|
| NSE Symbol | AGARWALEYE | PARKHOSPS |
| BSE Code | 544350 | 544645 |
| Share Price | ₹537.00 | ₹267.40 |
| Market Cap | ₹16,290 Cr | ₹9,670 Cr |
| P/E Ratio | 122.9 | 34.5 |
| Return on Equity | 8.31% | 13.00% |
| Return on Assets | 4.81% | 9.66% |
| Beta (1Y) | 0.26 | 0.93 |
| 1-Year Price Change | +6.1% | — |
| 3-Month Price Change | -4.2% | -7.5% |
| 52-Week Range | ₹401.00 – ₹567.75 | ₹138.10 – ₹305.00 |
| Latest Quarter | Q2 FY27 | Q1 FY27 |
| Quarterly Revenue | ₹655 Cr | ₹476 Cr |
| Quarterly Net Profit | ₹57 Cr | ₹89 Cr |
| Net Margin | 8.7% | 18.6% |
| EPS (Basic, Quarter) | ₹1.65 | ₹2.05 |
| Results Basis | consolidated | consolidated |
| Headquarters | Chennai, Tamil Nadu | Gurugram, Haryana |
The figures sit side by side and are not ranked. Quarterly figures are in ₹ crore, parsed from each company's exchange filing (XBRL); the two companies' latest quarters can differ.
Dr. Agarwal's Health Care Limited engages in running, owning, and managing eye care hospitals, opticals, pharmacies, etc. and related services in India and internationally. It offers femto cataracts, lenticular procedure, retinal surgeries, anterior segment reconstruction, and corneal transplants, as well as refractive and other surgeries. The company also develops, designs, manufactures, imports, and exports healthcare devices, which include ophthalmic diagnostic devices, such as auto perimeter, optical biometers, and ophthalmoscopes. In addition, the company offers consultations, diagnoses, …
Park Medi World Limited operates a network of hospitals. The company provides cardiac sciences, neurosciences - brain and spine, plastic and cosmetic surgery, general and laparoscopic surgery, renal sciences and kidney transplant, bone, orthopaedics, joint replacement and sports medicine, gastroenterology and surgical gastroenterology, cancer care, bone marrow transplant, iMARS / robot-assisted surgery. It also offers bariatric surgery, anaesthesiology, critical care, chest and respiratory diseases, dental care, dermatology, endocrinology, paediatrics, internal medicine and geriatrics, rheumat…
Dr. Agarwal's Health Care has a market capitalisation of ₹16,290 Cr, against ₹9,670 Cr for PARK MEDI WORLD as of 9 Nov 2026, about 1.7 times the size by market cap.
Dr. Agarwal's Health Care has a P/E of 122.9 and PARK MEDI WORLD a P/E of 34.5 as of 9 Nov 2026.
Dr. Agarwal's Health Care has a return on equity of 8.31% and PARK MEDI WORLD 13.00%.
Dr. Agarwal's Health Care reported revenue of ₹655 Cr and net profit of ₹57 Cr for Q2 FY27. PARK MEDI WORLD reported revenue of ₹476 Cr and net profit of ₹89 Cr for Q1 FY27. Figures are parsed from each company's exchange filing.
Both are classified under Health Care Providers and Services > Health Care Facilities > Hospitals and Healthcare Centers on FinBizNet.
No. The page lays the two companies' published figures side by side and draws no conclusion from them. It is descriptive market data, not investment advice.
Data as of 9 Nov 2026. Descriptive market data only — not investment advice.